Barclays analyst Peter Lawson raised the price target on Relay Therapeutics (NASDAQ: RLAY) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Hot Comments Momentum Movers

Goldman Sachs Reinstates Relay Therapeutics (RLAY) at BuySeptember 9, 2024 4:47 PM TD Cowen Out Positive on Relay Therapeutics (RLAY), Shares Up ~53%, 'we are constructive on Ph3 success based on today's data'September 9, 2024 3:20 PM Form 8-K Relay Therapeutics, Inc. For: Sep 09September 9, 2024 8:01 AM Relay Therapeutics (RLAY) Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free SurvivalSeptember 9, 2024 6:57 AM Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free SurvivalSeptember 9, 2024 6:55 AM Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024September 6, 2024 4:05 PM